Product cited in:
Carrasquer, Nebane, Williams et al.: "Functional consequences of nonsynonymous single nucleotide polymorphisms in the CB2 cannabinoid receptor." in: Pharmacogenetics and genomics, Vol. 20, Issue 3, pp. 157-66, 2010 (PubMed).
Guida, Ligresti, De Filippis et al.: "The levels of the endocannabinoid receptor CB2 and its ligand 2-arachidonoylglycerol are elevated in endometrial carcinoma." in: Endocrinology, Vol. 151, Issue 3, pp. 921-8, 2010 (PubMed).
De Jesús, Hostalot, Garibi et al.: "Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas." in: Neurochemistry international, Vol. 56, Issue 6-7, pp. 829-33, 2010 (PubMed).
Pinheiro, Bulik, Thornton et al.: "Association study of 182 candidate genes in anorexia nervosa." in: American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, Vol. 153B, Issue 5, pp. 1070-80, 2010 (PubMed).
Bailey, Xie, Do et al.: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, 2010 (PubMed).